Fractyl Health faces Nasdaq delisting risk after failing $1 minimum bid rule

• Fractyl Health faces potential Nasdaq delisting for failing the $1 minimum bid-price rule under Listing Rule 5450(a)(1).
• Nasdaq issued a delisting notice dated Sept. 10, 2026, following a 180-day compliance window that ended Sept. 9, 2026.
• A requested hearing would automatically stay any suspension or delisting, keeping the stock trading during the review.
• Compliance requires a closing bid of at least $1 for 10 consecutive business days, up to 20 at Nasdaq’s discretion.
• A proxy filed Aug. 24, 2026 seeks shareholder approval for a 1-for-5 to 1-for-15 reverse stock split.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fractyl Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-389291), on September 11, 2026, and is solely responsible for the information contained therein.